Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Dec 10, 2019
Date Accepted: Aug 25, 2020
Virtual Reality relaxation for patients with a psychiatric disorder: cross-over randomized controlled trial
ABSTRACT
Background:
Stress management is a cornerstone of psychiatric treatments. However, stress-reducing interventions (e.g., relaxation exercises) are challenging for people with mental health problems. We developed a virtual reality (VR) self-management relaxation tool with immersive 360o nature videos and interactive animated elements.
Objective:
To investigate the immediate and short-term effects of VR relaxation (VRelax) on stress level, mood states and symptoms in patients with a psychiatric disorder, compared to standard relaxation exercises.
Methods:
A randomized cross-over trial was conducted in 50 patients receiving ambulatory treatment for anxiety, psychotic, depressive or bipolar disorder. Participants were randomly assigned to start with VRelax or standard relaxation, and used both interventions for 10 days at home. They completed Visual Analogue Scales (VAS) of stress level and mood states before and after each session. Global perceived stress and psychiatric symptoms were measured before and after both intervention periods. Treatment effects were analyzed with multilevel repeated-measures regression models and two-way ANOVA.
Results:
Both VRelax and standard relaxation exercises led to a statistically significant immediate reduction of stress and improvement of mood states. Compared to standard relaxation, VRelax resulted in a significantly greater immediate improvement of anxiety (B=-4.30, 95%CI=-5.86;-2.73), sadness (B=-3.65, 95%CI =-5.39;-1.91), cheerfulness (B=3.67, 95%CI=2.15;5.18), overall positive mood (B=7.59, 95%CI=2.28;12.89), and overall negative mood (B=10.88, 95%CI=5.89;15.87). There were no significant differences between short-term effects of the two treatments on symptoms and global perceived stress.
Conclusions:
If the results of this trial are replicated and extended, VRelax may provide a much needed effective self-management stress intervention to enhance psychiatric treatments. Clinical Trial: Dutch trial register, number NTR 7294.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.